Home » Glaxo’s Successor to Advair Shaping Up in Tests
Glaxo’s Successor to Advair Shaping Up in Tests
GlaxoSmithKline gave a promising glimpse on Wednesday of a planned once-daily successor to its blockbuster lung treatment Advair, with results from a small study showing it compared well with the original product.
CNBC
CNBC
Upcoming Events
-
25Apr
-
07May
-
14May
-
30May